GVR Report cover 5-Hydroxytryptophan Market Size, Share & Trends Report

5-Hydroxytryptophan Market Size, Share & Trends Analysis Report By Application, Regional Outlook, Competitive Strategies, And Segment Forecasts, 2019 To 2025

  • Report ID: GVR1184
  • Number of Pages: 0
  • Format: Electronic (PDF)

The global 5-Hydroxytryptophan market is expected to grow owing to increasing stress levels in individuals on account of hormonal changes and improper diet resulting in a decrease in serotonin levels over the forecast period. Increasing anti-depressants demand due to the growing prevalence of anxiety, induced loss of appetite, and pain sensation is anticipated to propel 5-hydroxytryptophan market demand over the next six years. Irregular supply and fluctuating raw material prices are expected to act as a restraint on market growth. In addition, stringent government regulations and a lack of awareness among end-users are anticipated to pose a challenge for 5-hydroxytryptophan market participants. Furthermore, existing side effects of 5-HTP including stomach pain, heartburn, nausea, diarrhea, vomiting, muscle problems, and drowsiness is estimated to hinder the market growth. The increasing use of eco-friendly 5-HTP as a substitute for chemically synthesized tryptophan is expected to fuel market growth over the forecast period. In addition, R&D in genetic components is expected to cater to market growth opportunities.

North America was the largest consumer of 5-HTP over the past five years followed by Europe and Asia Pacific. Asia Pacific is expected to witness high growth in terms of consumption and production of 5-HTP owing to the emergence of numerous small and medium-sized manufacturers over the forecast period. Furthermore, changing lifestyles have led to huge capacity expansions in Asia Pacific. Technological advancements in emerging economies such as India and China have potential growth opportunities; although unfavorable drug regulations and lack of awareness could pose challenges to the market demand. Increasing applications in pharmaceuticals, food & beverage, and dietary supplements are estimated to augment market growth over the next six years. Dietary supplements are expected to witness swift growth owing to the increasing demand for artificial body nutrients. Increasing consumption of 5-HTP for treatment of insomnia, anxiety, depression, fibromyalgia, migraine, binge-eating associated with obesity, attention deficit-hyperactivity disorder (ADHD), premenstrual syndrome (PMS), premenstrual dysphoric disorder (PMDD), Parkinson's disease and seizure disorder is anticipated to have a positive impact on the market share.

Key players in the 5-hydroxytryptophan market include Flynn Pharma Ltd., Fidia Farmeceutici Spa, Linnea SA, Aspen Pharma, Chemill Inc, Takeda Pharmaceuticals International GmbH, Cactus Botanics, SanHerb Biotech Co. Ltd., and Jiaherb Inc. 

gvr icn


gvr icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.